A potent nonpeptide neuropeptide Y Y1 receptor antagonist, a benzodiazepine derivative

Life Sciences

Volumn 63, Issue 11, 1998, Pages A151-A160

  Shigeri, Yasushi ^a,b   Ishikawa, Michio ^a   Ishihara, Yasunobu ^a   Fujimoto, Masafumi ^a  

^a SHIONOGI AND CO LTD   (Japan)

^b NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY AIST   (Japan)

Author keywords

Antagonist; Cholecystokinin; Histamine; Neuropeptide Y; Y1 receptor

Indexed keywords

2,4 DIOXO 1,5 BIS(2 OXO 2 ORTHOTOLYL ETHYL) 3 [3 [3 [[3 [3 (3 PIPERIDIN 1 YLMETHYL PHENOXY)PROPYLCARBAMOYL]PROPYL]CARBAMOYLOXYMETHYL]PHENYL]UREIDO] 2,3,4,5 TETRAHYDRO 1H BENZO[B][1,4]DIAZEPINE; BENZODIAZEPINE DERIVATIVE; NEUROPEPTIDE Y; NEUROPEPTIDE Y RECEPTOR ANTAGONIST; NEUROPEPTIDE Y1 RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CARDIOVASCULAR DISEASE; CHO CELL; CONTROLLED STUDY; DRUG MECHANISM; DRUG RECEPTOR BINDING; DRUG STRUCTURE; DRUG SYNTHESIS; HUMAN; HUMAN CELL; NEUROBLASTOMA CELL; NONHUMAN; STRUCTURE ACTIVITY RELATION;

EID: 0032493762     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0024-3205(98)00357-9     Document Type: Article

References (16)

1. 1. C. WAHLESTEDT and D. REIS, Ann. Rev. Pharmacol. Toxicol. 32, 309-352 (1993).
2. 2. A. BLOMQVIST and H. HERZOG, Trends Neurosci. 20, 294-298 (1997).
3. 3. J. WRIGHT, Drug Discovery Today 2, 19-24 (1997).
4. 4. A. BALASUBRAMANIAM, W. ZHAI, Z. TAO, Y. HUANG, J. FISCHER, P. EDEN, J. TAILOR, L. KAR, S. SAMARASINGHE and M. JOHNSON, Peptides 17, 1113-1118 (1996).
5. 5. A. BALASUBRAMANIAM, W. ZHAI, S. SHERIFF, Z. TAO, W. CHANCE, J. FISCHER, P. EDEN and J. TAILOR, J. Med. Chem. 39, 811-813 (1996)
6. 6. A. DANIELS, J. MATTHEWS, R. SLEPETIS, M. JANSEN, O. VIVEROS, A. TADAPALLI, W. HARRINGTON, D. HEYER, A. LANDAVAZO, J. LEBAN and A. SPALTENSTEIN, Proc. Natl. Acad. Sci. U.S.A. 92, 9067-9071 (1995).
7. 7. K. KODUKULA, M. ARCURI, J. CUTRONE, R. HUGILL, S. LOWE, D. PIRNIK, Y. SHU, P. FERNANDES and R. SEETHALA, J. Antibiotics 48, 1055-1059 (1995).
8. 8. Y. SHIGERI and M. FUJIMOTO, J. Biol. Chem. 269, 8842-8848 (1994).
9. 9. Y. SHIGERI and M. FUJIMOTO, Biochem, Biophys. Res. Commun. 187, 1565-1571 (1992).
10. 10. Y. HU, B. BLOOMQUIST, L. CORNFIELD, L. DECARR, J. FLORES-RIVEROS, L. FRIEDMAN, P. JIANG, L. LEWIS-HIGGINS, Y. SADLOWSKI, J. SCHAEFER, N. VELAZQUEZ and M. MCCALEB, J. Biol. Chem. 271, 26315-26319 (1996)
11. 11. A. SAITO, I. GOLDFINE and J. WILLIAMS, J. Neurochem. 37, 483-490 (1981).
12. 12. A. ASH and H. SCHILD, Br. J. Pharmacol. 27, 427-439 (1966).
13. 13. Y. KAWANISHI, S. ISHIHARA, T. TSUSHIMA, S. HAGISHITA, M. ISHIKAWA and Y. ISHIHARA, Bioorg. Med. Chem. 5, 1401-1409 (1997).
14. 14. S. HAGISHITA, K. SENO, S. KAMATA, N. HAGA, Y. ISHIHARA, M. ISHIKAWA and M. SHIMAMURA, Bioorg. Med. Chem. 5, 1433-1446 (1997).
15. 15. Y. SHAO and K. MCCARTHY, Mol. Pharmacol. 44, 247-254 (1993)
16. 16. S. KNIEPS, M. MICHEL, S. DOVE and A. BUSCHAUER, Bioorg. Med. Chem. Lett. 5, 2065-2070 (1995).